Inside Innovation

Impel NeuroPharma (Impel), a Seattle-based biotech company led by Adrian Adams, has indicated the company plans to go public. According to GeekWire, Impel filed paperwork

Outpace Bio, a biotech company based in Seattle, announced it has raised $30M in a Series A round, led by ARTIS Ventures and Lyell. Outpace,

OncoResponse, a Seattle biotech company focused on developing antibodies to make immunotherapy treatments, announced a $40.6M Series C investment round. The additional founding, led by

According to a new JLL report titled, “Life Sciences Emerging Markets Index: Poised for a paradigm shift,” Seattle is the fastest growing area for life

Washington is the fourth-best state in the U.S. for remote job seekers, according to a new study by CareerCloud. This ranking is based on data

Vancouver, Washington-based AbSci raised $125 million in a recent funding round, bringing the company’s total funding up to $230 million. The capital will further AbSci’s growth

Seattle startup Curi Bio raised $6 million in a Series A funding round to further develop its human stem cell-based platforms for drug discovery. The

Eliem Therapeutics, a clinical stage biotechnology company focused on developing therapies for neuronal excitability disorders, emerged from stealth with $80 million in capital and two

Bristol Myers Squibb’s Bothell manufacturing facility has been designated as one of the production facilities for the company’s newly-approved cancer treatment, Breyanzi. The facility has

Seattle’s life science cluster has been named the fifth-best in America according to a report by commercial real estate firm Newmark. The report emphasized the

Nearly 12 months after experiencing the U.S.’s first widespread COVID-19 outbreak, Seattle has recorded the lowest COVID-related death rate of the 20 largest metropolitan regions

For the second year in a row, Washington has been named the best state in the U.S. by U.S. News & World Report. The 2021